Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 2/20 | 0.75 |
| ▸ | NPC1 | O15118 | 2/20 | 0.72 |
| ▸ | RAB9A | P51151 | 2/20 | 0.72 |
| ▸ | HPGD | P15428 | 6/20 | 0.69 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.69 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.61 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.61 |
| ▸ | MAPT | P10636 | 1/20 | 0.61 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.58 |
| ▸ | HTT | P42858 | 2/20 | 0.56 |
| ▸ | GRIN2D | O15399 | 2/20 | 0.56 |
| ▸ | GRIN3B | O60391 | 2/20 | 0.56 |
| ▸ | GRIN1 | Q05586 | 2/20 | 0.56 |
| ▸ | GRIN2A | Q12879 | 2/20 | 0.56 |
| ▸ | GRIN2B | Q13224 | 2/20 | 0.56 |
| ▸ | GRIN2C | Q14957 | 2/20 | 0.56 |
| ▸ | GRIN3A | Q8TCU5 | 2/20 | 0.56 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.56 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29521664 | 1.00 | POLB (0.75) | POLBNPC1RAB9AHPGDALDH1A1 | |
| Hydrochloric Acid SCHEMBL27918048 | 0.98 | POLB (0.72) | POLBNPC1RAB9AHPGDALDH1A1 | |
| Phosphine SCHEMBL30387635 | 0.98 | POLB (0.72) | POLBNPC1RAB9AHPGDALDH1A1 | |
| Carbamic Acid SCHEMBL11482904 | 0.87 | RAB9A (0.67) | POLBNPC1RAB9AHPGDALDH1A1 | |
| SCHEMBL1272314 | 0.86 | POLB (1.00) | POLBNPC1RAB9AHPGDALDH1A1 | |
| SCHEMBL25356036 | 0.85 | NPC1 (0.77) | POLBNPC1RAB9AHPGDALDH1A1 | |
| SCHEMBL29892467 | 0.85 | MAPT (0.61) | POLBNPC1RAB9AALDH1A1HSD17B10 | |
| SCHEMBL1140606 | 0.85 | MAPT (0.61) | POLBNPC1RAB9AALDH1A1HSD17B10 | |
| SCHEMBL29840068 | 0.85 | GAA (0.67) | POLBNPC1RAB9AHPGDALDH1A1 | |
| SCHEMBL3928666 | 0.85 | GAA (0.67) | POLBNPC1RAB9AHPGDALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 417 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250297039-A1 | OLEFIN POLYMERIZATION CATALYST COMPONENTS CONTAINING DIGLYCIDYLESTER COMPONENTS AND ITS USE FOR THE PRODUCTION OF POLYPROPYLENE HAVING HIGH ISOTACTICITY AT HIGH MELT FLOW RATE | FORMOSA PLASTICS CORP USA (US) | 2025-09-25 | — | — | US | claimed |
| CN-113906321-B | Polarizing plate, method for manufacturing same, and image display device | 住友化学株式会社 | 2024-10-15 | — | — | CN | claimed |
| US-20240262801-A1 | COMPOUNDS HAVING 5-(2-FLUORO-6-HYDROXYPHENYL)-1,2,5-THIADIAZOLIDIN-3-ONE 1,1-DIOXIDE AS INHIBITORS OF PROTEIN KINASE PHOSPHATASE ENZYMES | MONDEGO BIO, LDA. (PT) | 2024-08-08 | — | — | US | claimed |
| CN-117617257-A | Fungicidal compositions and methods of using the same | 江苏中旗科技股份有限公司 | 2024-03-01 | — | — | CN | claimed |
| CN-115583989-B | SSTR 2-targeted compound and preparation method and application thereof | 烟台蓝纳成生物技术有限公司 | 2023-02-28 | — | — | CN | claimed |
| CN-115583989-A | SSTR 2-targeted compound and preparation method and application thereof | 烟台蓝纳成生物技术有限公司 | 2023-01-10 | — | — | CN | claimed |
| CN-112250661-B | Method for catalytically synthesizing lactide | 南京大学 | 2021-11-02 | — | — | CN | claimed |
| CN-112250661-A | Method for catalytically synthesizing lactide | 南京大学 | 2021-01-22 | — | — | CN | claimed |
| CN-111826151-A | Dialkyl urea type supermolecule thickening agent and preparation method and application thereof | 中国石油大学(华东) | 2020-10-27 | — | — | CN | claimed |
| CN-109414420-A | The inhibitor and its application method of indole amine 2,3-dioxygenase | 百时美施贵宝公司 | 2019-03-01 | — | — | CN | claimed |
| US-20060281725-A1 | Agents and crystals for improving excretory potency of urinary bladder | ISIHARA YUJI | 2006-12-14 | — | — | US | claimed |
| CN-1850793-A | Water phase high pressure method for preparing N,N'-di (m-tolyl) urea | UNIV ZHEJIANG (CN) | 2006-10-25 | — | — | CN | claimed |
| EP-1604653-A1 | Acetylcholinesterase inhibitors for improving excretory potency of urinary bladder | Takeda Pharmaceutical Company Limited (JP) | 2005-12-14 | — | — | EP | claimed |
| US-20040116457-A1 | Agents for improving excretory potency of urinary bladder | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2004-06-17 | — | — | US | claimed |
| US-20020177593-A1 | Agents and crystals for improving excretory potency of urinary bladder | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2002-11-28 | — | — | US | claimed |
| EP-1118322-A1 | DRUGS FOR IMPROVING VESICAL EXCRETORY STRENGTH | Takeda Chemical Industries, Ltd. (JP) | 2001-07-25 | — | — | EP | claimed |
| CN-1283181-A | Substituted beta-alanines | AWONGTISFAMA CO LTD (GB) | 2001-02-07 | — | — | CN | claimed |
| CN-1265672-A | Sulphonylated dipeptide Compounds capable of inhibiting leukocyte adhesion mediated by VLA-4 | ELAND PHARMACEUTICALS CO (US) | 2000-09-06 | — | — | CN | claimed |
| EP-1005459-A1 | SUBSTITUTED ISOQUINOLINES AS ANTICONVULSIVANTS | SMITHKLINE BEECHAM PLC (GB) | 2000-06-07 | — | — | EP | claimed |
| WO-1999014197-A1 | SUBSTITUTED ISOQUINOLINES AS ANTICONVULSIVANTS | SMITHKLINE BEECHAM PLC (GB) | 1999-03-25 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240262801-A1 | COMPOUNDS HAVING 5-(2-FLUORO-6-HYDROXYPHENYL)-1,2,5-THIADIAZOLIDIN-3-ONE 1,1-DIOXIDE AS INHIBITORS OF PROTEIN KINASE PHOSPHATASE ENZYMES | PPM1A, TH, PPM1G | POLB 1935/4885NPC1 2925/4885RAB9A 2110/4885 |
| US-20020177593-A1 | Agents and crystals for improving excretory potency of urinary bladder | ACHE, BPHL, BCHE | POLB 2405/4885NPC1 1932/4885RAB9A 1071/4885 |
| US-20060281725-A1 | Agents and crystals for improving excretory potency of urinary bladder | ACHE, BCHE, PDE7A | POLB 1689/4885NPC1 2214/4885RAB9A 812/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.